Obstructive Sleep Apnoea/Hypopnoea Syndrome 21st September 2021

Dr Hussain presented a Summary of updated NICE guidance related to the Diagnosis and Management of Obstructive Sleep Apnoea/Hypopnoea syndrome. 
Key learning points were:
  • Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS), Obesity Hypoventilation Syndrome (OHS) and COPD-OSAHS overlap syndrome are common yet under-recognised conditions. It is estimated that 5 % of the UK population have undiagnosed OSAHS. 
  • Do not use Epworth Sleepiness Score alone to determine if a referral is needed, because not all people with OSAHS have excessive sleepiness.
  • The STOP-Bang Questionnaire is a useful tool to assess risk of OSAHS. 
  • Consider screening patients with nocturia, erectile dysfunction, cognitive impairment and mood disorders for OSAHS. 
  • A person can be a normal weight and still have OSAHS, even though obesity is a strong risk factor. 
  • Prevalence may be higher in Black, Hispanic and Asian populations
  • Consider screening for OSAHS in patients with conditions with a higher prevalence e.g. hypothyroidism, PCOS and treatment-resistant hypertension. 
The presentation is attached below:

Please be aware that information in the field of medicine changes all the time, so we cannot guarantee the accuracy of this data when you read it, it is here for General Practitioners to learn.